Publication | Closed Access

Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model

NanoparticlesNanomedicineNeuro-oncologyVivo Glioblastoma GrowthEngineeringDrug TargetingTherapeutic NanomaterialsMedicineIntranasal Route SuppressesPharmaceutical NanotechnologyIntracranial Mouse ModelNano-drug DeliveryTumor TargetingBiomedical EngineeringHigh-grade GliomasRadiation OncologyPharmacologyGlioma